Filing Details
- Accession Number:
- 0001104659-24-036284
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-19 19:50:25
- Reporting Period:
- 2024-03-09
- Accepted Time:
- 2024-03-19 19:50:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124524 | Cryoport Inc. | CYRX | Pharmaceutical Preparations (2834) | 880313393 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1848218 | W Mark Sawicki | C/O Cryoport Inc. 112 Westwood Place, Suite 350 Brentwood TN 37027 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-09 | 2,666 | $0.00 | 75,791 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-11 | 1,418 | $16.35 | 74,373 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-15 | 1,312 | $15.43 | 73,061 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-03-15 | 5,750 | $0.00 | 78,811 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Rights | Disposition | 2024-03-09 | 2,666 | $0.00 | 2,666 | $0.00 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2024-03-15 | 11,500 | $0.00 | 11,500 | $16.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,667 | No | 4 | M | Direct | ||
| 11,500 | 2031-03-15 | No | 4 | A | Direct |
Footnotes
- Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
- Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
- Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025.
- The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024.
- 1/48 of options vest on the 15th of each month for forty-eight months beginning April 25, 2024.
Billionaire Hedge Funds
